MiMedx Group, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6024961012
USD
3.67
0.06 (1.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Stevanato Group SpA
LeMaitre Vascular, Inc.
Establishment Labs Holdings, Inc.
Tandem Diabetes Care, Inc.
Paragon 28, Inc.
MiMedx Group, Inc.
Quanterix Corp.
Avanos Medical, Inc.
Alphatec Holdings, Inc.
Myriad Genetics, Inc.
Owens & Minor, Inc.

Why is MiMedx Group, Inc. ?

1
The company has declared negative results in Mar'2026 after 2 consecutive positive quarters
  • ROCE(HY) Lowest at 13.77%
  • RAW MATERIAL COST(Y) Grown by 13.82% (YoY)
  • NET SALES(Q) Lowest at USD 58.99 MM
2
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -37.80% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MiMedx Group, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
MiMedx Group, Inc.
-37.8%
-1.10
43.33%
S&P 500
25.41%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.02%
EBIT Growth (5y)
28.03%
EBIT to Interest (avg)
3.60
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
1.71
Tax Ratio
26.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
75.98%
ROCE (avg)
16.68%
ROE (avg)
13.42%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
2.22
EV to EBIT
6.61
EV to EBITDA
5.36
EV to Capital Employed
3.85
EV to Sales
1.01
PEG Ratio
0.84
Dividend Yield
NA
ROCE (Latest)
58.23%
ROE (Latest)
18.94%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 70.59 MM

DEBT-EQUITY RATIO (HY)

Lowest at -58.53 %

CASH AND EQV(HY)

Highest at USD 325.89 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.96 times

DEBTORS TURNOVER RATIO(HY)

Highest at 7.19 times

-22What is not working for the Company
ROCE(HY)

Lowest at 13.77%

RAW MATERIAL COST(Y)

Grown by 13.82% (YoY

NET SALES(Q)

Lowest at USD 58.99 MM

OPERATING PROFIT(Q)

Lowest at USD -14.43 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -24.46 %

PRE-TAX PROFIT(Q)

Lowest at USD -15.33 MM

NET PROFIT(Q)

Lowest at USD -10.86 MM

EPS(Q)

Lowest at USD -0.07

Here's what is working for MiMedx Group, Inc.

Operating Cash Flow
Highest at USD 70.59 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at -58.53 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Cash and Eqv
Highest at USD 325.89 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio
Highest at 2.96 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 7.19 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for MiMedx Group, Inc.

Net Sales
At USD 58.99 MM has Fallen at -43.63%
over average net sales of the previous four periods of USD 104.66 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit
At USD -15.33 MM has Fallen at -192.55%
over average net sales of the previous four periods of USD 16.57 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -10.86 MM has Fallen at -189.42%
over average net sales of the previous four periods of USD 12.15 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Sales
Lowest at USD 58.99 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (USD MM)

Operating Profit
Lowest at USD -14.43 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin
Lowest at -24.46 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at USD -15.33 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -10.86 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD -0.07
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Raw Material Cost
Grown by 13.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales